» Articles » PMID: 8465203

Altered Growth of Human Colon Cancer Cell Lines Disrupted at Activated Ki-ras

Overview
Journal Science
Specialty Science
Date 1993 Apr 2
PMID 8465203
Citations 256
Authors
Affiliations
Soon will be listed here.
Abstract

Point mutations that activate the Ki-ras proto-oncogene are presented in about 50 percent of human colorectal tumors. To study the functional significance of these mutations, the activated Ki-ras genes in two human colon carcinoma cell lines, DLD-1 and HCT 116, were disrupted by homologous recombination. Compared with parental cells, cells disrupted at the activated Ki-ras gene were morphologically altered, lost the capacity for anchorage-independent growth, grew more slowly both in vitro and in nude mice, and showed reduced expression of c-myc. Thus, the activated Ki-ras gene plays a key role in colorectal tumorigenesis through altered cell differentiation and cell growth.

Citing Articles

5-Fluorouracil treatment represses pseudouridine-containing miRNA export into extracellular vesicles.

Qu S, Nelson H, Liu X, Wang Y, Semler E, Michell D J Extracell Biol. 2024; 3(9):e70010.

PMID: 39281020 PMC: 11393769. DOI: 10.1002/jex2.70010.


Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives.

Shi X, Wang X, Yao W, Shi D, Shao X, Lu Z Signal Transduct Target Ther. 2024; 9(1):192.

PMID: 39090094 PMC: 11294630. DOI: 10.1038/s41392-024-01885-2.


Impact of carbamazepine on SMARCA4 (BRG1) expression in colorectal cancer: modulation by KRAS mutation status.

Shaykevich A, Chae D, Silverman I, Bassali J, Louloueian N, Siegman A Invest New Drugs. 2024; 42(2):229-239.

PMID: 38446332 PMC: 10944448. DOI: 10.1007/s10637-024-01418-2.


Culture conditions greatly impact the levels of vesicular and extravesicular Ago2 and RNA in extracellular vesicle preparations.

Jimenez L, Barman B, Jung Y, Cocozza L, Krystofiak E, Saffold C J Extracell Vesicles. 2023; 12(11):e12366.

PMID: 37885043 PMC: 10603024. DOI: 10.1002/jev2.12366.


Aneuploidy in human cancer: new tools and perspectives.

Lakhani A, Thompson S, Sheltzer J Trends Genet. 2023; 39(12):968-980.

PMID: 37778926 PMC: 10715718. DOI: 10.1016/j.tig.2023.09.002.